Cyclopharm Limited

ASX:CYC ISIN:AU000000CYC5

The Company produces and supplies the medical profession with proprietary lung radiopharmaceuticals.  
 

News

Cyclopharm Limited (ASX:CYC) Important Milestones in Nuclear Medicine

🕔5/29/2013 11:41:30 PM 11748

Cyclopharm Limited (ASX:CYC) is an Australian-based company manufacturing and selling nuclear medicine equipment, radiopharmaceuticals and related research and development services. The company specializes in imaging of lungs (Technegas system) and molecular imaging radiopharmaceuticals used in cancer, brain and cardiac imaging.

Read Full Article▸

Cyclopharm Limited ASX: CYC - Half Year Presentation - Mr John Sharman, MD

🕔8/30/2007 2:09:00 PM 3711

Cyclopharm Limited (ASX: CYC) - Half Year Presentation - Mr John Sharman, MD; Cyclopharm Limited (ASX: CYC) present the following audio webcast regarding "Half Year Presentation". You may also download this audio webcast to your computer or portable audio player.

Read Full Article▸

Cyclopharm Limited ASX: CYC - 2007 AGM Summary - Mr John Sharman, MD

🕔5/14/2007 1:58:00 PM 4086

Cyclopharm Limited [B@1d2a07e; Boardroomradio is pleased to announce that Cyclopharm Limited (ASX: CYC) has published an audio file.

Read Full Article▸
###

4,892 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 8) (Last 30 Days: 31) (Since Published: 4892) 

Company Data

    Principal Sector
  • Health & Pharm 
    • Principal Industry
  • Healthcare 

More News Results

  • 2025/09/02: 2025 Half-year Results Webinar Presentation*
  • 2025/08/27: Cyclopharm 1H2025 Results Webinar*
  • 2025/08/27: CYC 1H2025 Results Summary*
  • 2025/08/27: Half Yearly Report and Accounts*
  • 2025/07/16: CYC Appoints US Sales Vice President*
  • 2025/06/11: Cyclopharm Secures Maximum US Patent Extension for Technegas*
  • 2025/05/30: Results of AGM*
  • 2025/05/30: CYC 2025 AGM Presentation*
  • 2025/05/30: Managing Director's Address to Shareholders*
  • 2025/05/30: Chair's Address to Shareholders*
*refer to company website